CANNA VENTURES RAISES $1.4 MILLION TO FOCUS ON #INVESTMENTS
& LENDING IN #FUNCTIONALMUSHROOM & #PSYCHEDELIC
April 8, 2021 ( New York, NY)- (Investorideas.com
Newswire) Canna Ventures, LLC a private
equity cannabis fund based in Bridgehampton ,NY aimed at investing in
public & private small and micro cap companies. The new yet to be named
subsidiary will solely focus on the emerging functional mushroom &
psychedelic's space.
Read this in full
at
https://www.investorideas.com/news/2021/cannabis/04081Canna-Ventures.asp
The psychedelic drugs market is expected to gain market growth in the
forecast period of 2020 to 2027. Data Bridge Market
Research analyses that the market is
growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected
to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019.
Growing acceptance of psychedelic drugs for treating depression and increasing
prevalence of depression and mental disorders are the factors for the market
growth. The report says: "… psychedelic drugs are used to enhance or
change sensory perceptions, energy levels, thought processes, and to facilitate
spiritual experiences. Psychedelic drugs can be categorized into dissociative
drugs (such as PCP), empathogens and serotonergic (classic hallucinogens) (such
as LSD). These drugs are used in the treatment of major depressive disorder,
treatment-resistant depression, panic disorder, post-traumatic stress disorder,
and opiate addiction among others."
Medicinal psychedelics have shown great promise through a number of
studies conducted over the last fifteen years, but the scientific progress
being made in new and current studies over the last two years (and even within
the last few months) have accelerated exponentially. Psychedelics are gaining a
respectful and highly inquisitive position in the scientific community, which
is helping to destigmatize these substances from a societal perspective and
creating unprecedented opportunities in public trading markets.
“It’s crucial that we diversify outside of the cannabis industry. With
that said we want to allocate capital towards the functional mushroom
& psychedelic market. Our main focus will be lending & taking
equity stakes in publicly traded companies within the space ” said Mark G. Gomez,
co-founder of Canna Ventures.
For more info contact
No comments:
Post a Comment